PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.47−0.01 (-0.68%)
Close on Nov 18, 2026Market cap $1.31MP/E –Yield –
PMGC net income
Net income is the profit left for shareholders after every expense, interest and tax.
PMGC's net income for the twelve months ending Sep 30, 2026 was -$13.30M. For fiscal 2025 it was -$7.75M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.75M | – |
| FY2024 | Dec 31, 2024 | -$6.25M | – |
| FY2023 | Dec 31, 2023 | -$4.30M | – |
| FY2022 | Dec 31, 2022 | -$1.80M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.41M | – |
| Q2 FY2026 | Jun 30, 2026 | -$2.94M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.98M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.59M | – |
| Q2 FY2025 | Jun 30, 2025 | -$562.36K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.61M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.93M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.50M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.41M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.40M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.16M | -100.1% |
| Q3 FY2023 | Sep 30, 2023 | -$783.05K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.08M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.15B | – |
| Q3 FY2022 | Sep 30, 2022 | -$499.09M | – |
See a number that looks wrong?